What does MRI assess?
MRI provides detailed images of the prostate and suspicious areas. When biopsy is being considered, it may help identify targets for sampling. Findings are reviewed with PSA and other risk information. Imaging alone does not conclusively confirm or exclude cancer in every person. [1]
Understanding PI-RADS
PI-RADS is a system for reporting prostate MRI findings consistently. It is not a cancer stage or a definitive pathology diagnosis. A scan reporting a high level of suspicion and a biopsy demonstrating cancer are different steps. Further decisions depend on the imaging and clinical risk together. [1]
What biopsy adds
Tissue samples are examined under a microscope. If cancer is present, the examination provides information about its characteristics and grade. The clinician plans the sampling method and areas to be sampled. Results are interpreted alongside MRI and blood findings rather than as isolated documents. [1, 2]
Information to share before testing
Report all medicines, including blood thinners, allergies, previous infections and any pacemaker or metal implants. The team performing the test determines medicine adjustments and preparation. Obtain individual written instructions instead of stopping a medicine independently. It is also useful to know whom to contact if a new illness or medicine change occurs before the appointment.
Reviewing results and recovery
Ask when and by whom the result will be explained. After biopsy, fever, chills, inability to urinate or heavy bleeding requires attention according to the team’s urgent-care instructions. Even a normal or uncertain result should be accompanied by a clear follow-up plan: a single report does not necessarily settle every question about future monitoring. [1]
References
This article provides general health information. Consult your clinician for individual diagnosis and treatment decisions, and your pharmacist for questions about medicine use.
Published by Aymed İlaç · 17 October 2026